Air purifier firm heading for success?
A new means of purifying air based on a simple electronic device could mount a significant challenge to established players such as ultraviolet light and HEPA filters, according to analysts.
Archives for March 22, 2004
Academics embrace high-throughput screening
A brand new chemical genomics facility, one of the first academic small molecule screening facilities in Europe, has been opened by the European Molecular Biology Laboratory (EMBL) and the German Cancer Research Centre (DKFZ) in Heidelberg, Germany,...
UK govt and industry unveil R&D investment
The UK government has promised to protect the large funding increases for science announced in the country's last Spending Review and pledged more investment under a new 10-year strategy for science.
Testing drugs in tiny volumes
A new machine from Ultrasonic Scientific promises to revolutionise the analysis of chemical reactions by requiring only a tiny amount of sample, an important consideration when testing expensive biologic compounds.
Scientist decline could hamper UK R&D
The pharmaceutical industry in the UK could face a recruitment crisis if more is not done to encourage students to opt for science and engineering courses, according to the Association of the British Pharmaceutical Industry, writes Phil Taylor.
Sugars make proteins more human
Researchers in Austria have deciphered the first steps involved in the attachment of sugar groups to proteins - a process known as glycoslation - which could open the door to making a broad range of human proteins in bacteria, writes Phil Taylor.
Chinese chemical industry heads for consolidation?
Compared with European and US chemical companies, most domestic Chinese chemical enterprises have remained technologically challenged with productivity lagging behind international levels.
FDA to seek answer to pipeline blockage
The US Food and Drug Administration is to develop a blueprint for speeding up the approval of new medical products to counteract the slowdown in R&D productivity in the pharmaceutical industry, writes Phil Taylor.
Merger creates new force in life sciences
Fisher Scientific and Apogent Technologies are to merge in a $3.7 billion (€3.01bn) deal that will double Fisher's footprint in the high-growth life sciences equipment market, reports Phil Taylor.